Magnus Corfitzen will present at Redeye Orphan Drug Event with  Q&A panel discussions with  Redeye analysts. Live broadcast: https://www.redeye.se/events/870532/redeye-theme-orphan-drugs-2

Julie Waras Brogren, Deputy CEO and CCO will present Orviglance commercial opportunity and progress towards launch. To register: https://www.inderes.dk/videos/ascelia-pharma-orviglance-commercial-opportunity-and-progress-towards-launch

Ascelia Pharma investor update: bringing Orviglance to market - next steps towards launch Live webcast: link will be posted prior to the event.